In this review, we will discuss the progressive decline in cognitive and intellectual performance in late life that has led to great challenges for medical and community services. The term 'vascular cognitive impairment' is defined as any cognitive impairment that is caused by or associated with vascular factors. It can occur alone or in association with Alzheimer disease. The good news is that because vascular risk factors are treatable, it should be possible to prevent or delay some dementias. Since vascular cognitive impairment may often go unrecognized, many experts recommend screening with brief tests to assess memory, thinking, and reasoning for everyone considered to be at high risk for this disorder. Up to 64% of persons 65 years or older who have experienced a stroke have some degree of cognitive impairment with up to one third developing dementia. Postmortem studies indicate that up to 34% of dementia cases show significant vascular pathology. It suggests that ischemic stroke triggers additional pathophysiological process that may lead to a secondary degenerative process that may interact with Alzheimer disease pathology thus accelerating the ongoing primary neurodegeneration. Mechanisms could include hypoperfusion, hypoxia, and neuroinflammation, one of the links between the two pathologies. Stroke and dementia share the same risk and protective factors. Since stroke interact with dementia of all types it may already be possible to reduce or delay some dementias by a number of interventions known to prevent stroke.
The progressive decline in cognitive and intellectual performance in late life has led to greater challenges for medical and community services. It is an increasing concern for health care providers worldwide. In addition, we also have to consider the emotional impact on patients and caregivers.
The term 'vascular cognitive impairment' (VCI) was defined as any cognitive impairment that is caused by or associated with vascular factors (Hachinski 1994) . It can occur alone or in association with Alzheimer disease. The good news is that because vascular risk factors are treatable, it should be possible to prevent or delay some dementias.
Epidemiological evidence
The prevalence of asymptomatic infarcts in the Rotterdam study (Vermeer et al. 2003) increased with age, especially for asymptomatic infarcts. They occur about five times more often than symptomatic infarcts (Fig. 1) .
Although the patients were asymptomatic, they showed minor neurological signs.
Up to 64% of persons aged 65 years or older, who have experienced a stroke and cognitive impairment, especially processing speed and executive dysfunction, have some degree of cognitive impairment (Jin et al. 2006) . In a systematic review and meta-analysis on prevalence, incidence, and risk factors associated with pre-stroke and post-stroke dementia (Pendlebury and Rothwell 2009) , the authors found that 10% of patients had dementia before the first stroke, 10% developed new dementia soon after the first stroke and more than one third had dementia after a recurrent stroke. The mechanisms remain unclear beyond the fact that neurodegenerative and vascular mechanisms contribute to cognitive decline.
Pathological evidence
All neurodegenerative dementias have a vascular component ranging from 61% in frontotemporal dementia to 82% in Alzheimer disease. Moreover, the presence of a vascular component doubles the chances of developing dementia. The older individuals are, the more likely they are to have a vascular component (Toledo et al. 2013) .
Clinical
The REasons for Geographic and Racial Differences in Stroke Study showed that after a stroke in the acute phase, there is a loss of global cognition, new learning, and verbal memory. While in the post-stroke phase there is a faster global cognition and a decline of executive function with age suggesting that stroke triggers neurodegeneration (Levine et al. 2015) , perhaps by inducing inflammation (Thiel et al. 2014) .
Stroke and dementia share most risk and some protective factors. Some risks are not modifiable such as age, genetic factors, and family history, while other risk factors are modifiable such as hypertension, hypercholesterolemia, obesity, diabetes, smoking, high homocysteine, stress, depression, and atrial fibrillation (Table 1) .
Some factors are protective for both the diseases such as higher education, physical activity, an active lifestyle, and appropriate medications.
Transient ischemic attacks and minor strokes offer an immediate and great opportunity to prevent disabling strokes, myocardial infarction, and death and decrease the chances of developing dementia in patients with cognitive interventions, including cardiovascular and cerebrovascular conditions.
The association of atrial fibrillation with stroke risk has been long established, recently a study showed that up to a 48% reduction of dementia risk on patients with atrial fibrillation are anticoagulated compared to patients who are not (Friberg and Rosenqvist 2017) . The mechanisms probably include clinical stroke, silent stroke, and microemboli.
How to approach cognitive impairment
It is necessary to adopt and follow common minimal standards in describing VCI ). Once we identify a vascular component, we need to treat it. It is important to identify the most relevant history, family history, clinical, neuropsychological, and imaging elements that may identify the vascular component. Patients with VCI often have difficulties with executive function, difficulty in planning, multitasking, and problem solving. Patients with cognitive impairment after a clinical stroke represent a specific subgroup within VCI. Three months after a stroke, up to one third of patients meet criteria for vascular dementia (Pendlebury and Rothwell 2009) .
In the clinical assessment of patients, the first step is the clinician and a thorough clinical and family history to assess the risk of complex genetic diseases. The neurological examination provides important etiologic information in patients with cognitive decline. Signs such as a Parkinsonian gait, frequent falls, urinary frequency, or incontinence and pseudobulbar palsy may be present when cerebrovascular pathology affects subcortical structures. These aspects of subcortical disease are rare in patients with Alzheimer disease.
Prevention
Currently, the best way to prevent dementia is to prevent stroke. Lifestyle changes and intensive medical management including effective blood pressure control, antiplatelet agents, anticoagulants, and lipid-lowering therapy can reduce the risk of stroke and dementia. Appropriate endarterectomy or stenting of carotid stenosis may also reduce the risk of stroke and hence dementia. A number of lifestyle changes have the potential to delay cognitive decline: smoking cessation, moderate alcohol consumption, and exercise are all important. Many epidemiological studies have found an association between a history of metabolic syndrome, smoking, obesity, physical inactivity, poor diet, alcohol consumption, hypertension, hyperlipidemia, and diabetes mellitus. It is necessary to identify the presence of vascular risk factors and the age at which they manifest because these risk factors increase the risk of clinical stroke, subclinical cerebrovascular disease, and dementia (Gorelick et al. 2011) . It is well known that the Mediterranean diet significantly reduces the risk of stroke (Estruch et al. 2013; Safouris et al. 2015; Valls-Pedret et al. 2015) . Controlling blood pressure is perhaps the most effective medical intervention for stroke prevention, with the potential to reduce stroke by 40-50% (S€ or€ os et al. 2012) . Despite all the evidence that lowering blood pressure helps prevent stroke, hypertension remains poorly controlled. There is some evidence that the control of diabetes may reduce stroke, particularly stroke from intracranial stenosis, which is more common in diabetes (Luchsinger et al. 2015) . The new oral anticoagulants have made the management of patients with known or suspected cardioembolic stroke easier.
In the year 2000, the Province of Ontario (population 14 million) introduced a stroke strategy, which meant that more stroke units and stroke prevention clinics were built and public campaigns on the prevention of vascular risk factors were undertaken. Following the successful stroke strategy (Kapral et al. 2013) , outcomes after stroke and transient ischemic attacks after stroke improved (Webster et al. 2011) .
Knowing stroke doubles the chances of developing dementia (Savva and Stephan 2010) , the incidence of stroke and dementia were examined over a 12-year period. It was found that there was a decline in dementia concomitant with a decline in stroke. The incidence of stroke decreased by 32.4% and dementia by 7.4% (Sposato et al. 2015; Cerasuola et al. 2017) , suggesting that by preventing stroke, you can also prevent some dementias. Based on this and other evidence, the World Stroke Organization updated the World Stroke Proclamation to include potentially preventable dementias. The Proclamation has been endorsed by all the main organizations dealing with stroke and dementia, including Alzheimer Disease International, The World Heart Federation, the World Psychiatry Association, the World Federation of Neurology, the International Brain Research Organization, Public Health England, Alzheimer Association, American Academy of Neurology and the American Heart/Stroke Association, and 13 other international, regional, and national organizations (Hachinski 2015) (Fig. 2) .
Conclusions
Epidemiologic, pathologic, clinical, and experimental evidence suggests that cerebrovascular and Alzheimer diseases are not only fellow travelers, but also partners in crime. The Rotterdam study (Vermeer et al. 2003) , a prospective population-based study, showed that in the extended cohort, approximately one third of dementia could have been avoided by lifestyle changes and elimination of cardiovascular risk factors.
Since stroke interacts with dementia of all types, it may already be possible to reduce the rate of cognitive decline and delay some dementias by a number of interventions known to prevent stroke. Lifestyle interventions are far more important than most physicians assume. It is important to help patients quit smoking, adopt a Mediterranean diet, moderate their alcohol intake, and exercise regularly. Key medical and surgical interventions that reduce the risk of stroke include antiplatelet therapy, anticoagulation, and revascularization in appropriate cases.
The understanding of underlying pathophysiological mechanisms may lead to the advent of novel therapeutic options for neurovascular disease, a highly prevalent form of cognitive impairment.
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